Your browser doesn't support javascript.
loading
Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan.
Kashiwado, Yusuke; Kimoto, Yasutaka; Oku, Kenji; Yamamoto, Mari; Ohshima, Shiro; Ito, Satoshi; Horiuchi, Takahiko; Takeuchi, Tsutomu.
Affiliation
  • Kashiwado Y; Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
  • Kimoto Y; Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
  • Oku K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Kanagawa, Japan.
  • Yamamoto M; Department of Rheumatology and Nephrology, Chubu Rosai Hospital, Aichi, Japan.
  • Ohshima S; Department of Clinical Research, Rheumatology and Allergology, Osaka Minami Medical Center, Osaka, Japan.
  • Ito S; Department of Rheumatology, Niigata Rheumatic Center, Niigata, Japan.
  • Horiuchi T; Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
  • Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University, Tokyo, Japan.
Mod Rheumatol ; 34(3): 576-583, 2024 Mar 28.
Article in En | MEDLINE | ID: mdl-37338284
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Diseases / COVID-19 Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Mod Rheumatol Year: 2024 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatic Diseases / COVID-19 Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Mod Rheumatol Year: 2024 Type: Article Affiliation country: Japan